Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. [electronic resource]
Producer: 20070425Description: 315-22 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor -- blood
- Child
- Clinical Trials as Topic -- statistics & numerical data
- Computer Systems
- DNA, Complementary -- genetics
- Disease-Free Survival
- Drug Monitoring
- Female
- Follow-Up Studies
- Gene Dosage
- Humans
- Idarubicin -- administration & dosage
- Kaplan-Meier Estimate
- Leukemia, Promyelocytic, Acute -- blood
- Leukocyte Count
- Male
- Middle Aged
- Multicenter Studies as Topic -- statistics & numerical data
- Neoplasm, Residual
- Oncogene Proteins, Fusion -- blood
- Polymerase Chain Reaction -- methods
- Predictive Value of Tests
- RNA, Messenger -- blood
- RNA, Neoplasm -- blood
- Recurrence
- Remission Induction
- Risk Assessment
- Salvage Therapy
- Sensitivity and Specificity
- Survival Analysis
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.